A preliminary study, presented at the American Society of Clinical Oncology (ASCO) meeting in Boston, found that a Medicare subsidy program has made it easier for breast cancer patients to continue with the treatment they need. This improvement was found to be constant throughout all demographics and promotes continuation of hormone therapy after surgery. The study, detailed in a Medline Plus article, focused on over 23,000 early stage breast cancer patients.
The group included in ...
continue reading...